| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |